Health Highlights: June 14, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
More Sickened by Salmonella From Backyard Poultry
Having chickens or ducks in your yard might carry salmonella
FDA Approves Kanjinti
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin
THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (
More Aggressive Statin Tx Needed After Heart Attack in Young Patients
FRIDAY, June 14, 2019 -- The majority of young heart attack patients with familial hypercholesterolemia (FH) still have elevated cholesterol levels a year later, according to a study p
Lowering Cholesterol Levels May Worsen Nerve Damage in T2DM
WEDNESDAY, June 5, 2019 -- Lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy (DPN), according to a study published online May 31 in JA
Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result of a Sterility Test Failure
Audience: Consumer, Health Pro
FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache
INDIANAPOLIS, June 04, 2019 – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality (galcanezumab-